Atlas Trials

A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

Clinical trial NCT06878248 · TERMINATED

Trial details

NCT number
NCT06878248
Sponsor
Calibr, a division of Scripps Research
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer MetastaticLocally Advanced Breast Cancer (LABC)Malignant Neoplasm of BreastTriple Negative Breast Cancer (TNBC)Hormone Receptor-Positive Breast CancerHER2 + Breast Cancer
Start date
2025-04-17
Primary completion
2026-04-09
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.